Georgian Medical Journal analysis identifies three practical takeaways for patients evaluating magnesium supplements. First, form-specific organ-targeting claims marketed by supplement brands lack robust human clinical evidence—most derive from animal or cellular studies. Second, total magnesium intake proves more clinically relevant than the specific chemical form selected; absorption efficiency matters more than marketing positioning. Third, consumers seeking magnesium supplementation should prioritize well-absorbed forms like citrate and glycinate based on bioavailability data rather than purchasing premium-priced products marketed for organ-specific targets. While magnesium supplementation itself offers documented health benefits, the supplement industry’s tiered pricing structure around organ-specific formulations represents marketing strategy exceeding current scientific validation. Clinicians should help patients navigate this landscape by emphasizing evidence-based absorption considerations over premium targeted formulations. Read the full article on GMJ Newsroom.
Was this article helpful?
